Mayo clinic tests natural compound to fight frailty in seniors
NCT ID NCT03675724
Summary
This study is testing whether a natural compound called fisetin can help reduce frailty and signs of inflammation in the blood of older adults. Researchers at Mayo Clinic are enrolling 40 participants aged 70 and older to see if taking fisetin improves markers of frailty, inflammation, and bone health. This is a Phase 2 trial, meaning it's an early step to see if the treatment shows promise and is safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAIL ELDERLY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.